(Adds shares in paragraph 2, details in paragraph 3) Oct 30 (Reuters) – The US Food and Drug Administration has approved Inovio Pharmaceuticals' treatment for a rare respiratory condition, the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)